Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-6-2
pubmed:abstractText
It is not known whether androgen ablation therapy (AAT) influences TRAIL death ligand and its receptors expression of prostate cancer (PCa) cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1423-0399
pubmed:author
pubmed:copyrightInfo
Copyright (c) 2010 S. Karger AG, Basel.
pubmed:issnType
Electronic
pubmed:volume
84
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
445-51
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Effects of androgen ablation therapy in TRAIL death ligand and its receptors expression in advanced prostate cancer.
pubmed:affiliation
Human Gene Therapy Unit, Department of Urology, Faculty of Medicine, Akdeniz University, Antalya, Turkey. tkoksal @ akdeniz.edu.tr
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't